• <table id="gigg0"></table>
  • west china medical publishers
    Author
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Author "王洋" 27 results
    • 共刺激分子B7mRNA在大鼠缺血-再灌注損傷肺組織中的表達

      目的 進一步驗證B7-CD28共刺激通路在肺缺血-再灌注損傷中的作用. 方法 復制大鼠原位肺熱缺血-再灌注模型,將40只Wistar大鼠隨機分為假手術組、缺血30分鐘再灌注組,利用多聚酶鏈反應(RT-PCR)半定量技術檢測缺血-再灌注不同時相肺組織中共刺激分子B7的mRNA表達水平. 結果 正常和缺血肺組織中B7mRNA的表達處于極低水平,再灌注后肺組織中B7mRNA的表達開始逐漸升高,并于再灌注后48小時達高峰. 結論 缺血-再灌注后肺組織內B7mRNA的轉錄水平升高,進一步闡明了肺缺血-再灌注損傷與共刺激分子B7之間的聯系.

      Release date:2016-08-30 06:31 Export PDF Favorites Scan
    • 以夜間遺尿為首發癥狀的阻塞性睡眠呼吸暫停低通氣綜合征一例

      Release date:2023-08-16 02:13 Export PDF Favorites Scan
    • 以淋巴結腫大為表現的成人肺結核合并新型隱球菌感染一例

      Release date:2024-11-04 05:14 Export PDF Favorites Scan
    • 肺栓塞一例誤診分析

      臨床資料 患者女性, 31 歲。因“咳嗽、發熱 4 d, 憋氣伴上腹部不適1 d”于2011 年3 月30 日收入院。4 d 前患者無明顯誘因出現輕微咳嗽, 發熱, 體溫高達38. 5 ℃, 咳嗽不重, 咳少量白痰, 偶有痰中帶血絲, 無其他伴隨癥狀。發病第2 d 來我院急診, 查血C 反應蛋白( CRP) 30. 00 mg/L, 胸片、心電圖、血常規檢查未見明顯異常, 按“上呼吸道感染”給予輸液治療2 d, 癥狀無減輕。患者自覺乏力, 活動后憋氣, 上腹部隱痛, 飽脹感, 嘔吐2 次, 嘔出為內容物, 為進一步診治入院。此次發病以來患者無胸痛、盜汗、頭痛、頭暈、暈厥、腹痛、腹瀉、黑便等伴隨癥狀。既往體健, 月經規律, 無慢性病史。兒子4 歲, 1 周前曾因“急性支氣管炎”在我院兒科輸液治療 3 d, 患兒治療期間由患者照顧。家族中無陽性病史。

      Release date:2016-09-13 03:51 Export PDF Favorites Scan
    • Evaluation on the predictive values of six critical illness scores for ICU mortality in respiratory intensive care unit based on MIMIC-Ⅲ database

      ObjectiveTo evaluate the predictive value of critical illness scores for hospital mortality of severe respiratory diseases in respiratory intensive care unit (ICU).MethodsThe clinical data of the patients who needed intensive care and primary diagnosed with respiratory diseases from June, 2001 to Octomber, 2012 were extracted from MIMIC-Ⅲ database. The Acute Physiology Score (APS) Ⅲ, Simplified Acute Physiology Score (SAPS) Ⅱ, Oxford Acute Severity of Illness Score (OASIS), Logistic Organ Dysfunction System (LODS), Systemic Inflammatory Response Syndrome (SIRS) and Sequential Organ Failure Assessment (SOFA) were calculated according to the requirements of each scoring system. ICU mortality was set up as primary outcome and receiver operating characteristic (ROC) analysis was performed to evaluate the predictive performances by comparing the areas under ROC curve (AUC). According to whether they received invasive mechanical ventilation during ICU, the patients were divided into two groups (group A: without invasive mechanical ventilation group; group B: with invasive mechanical ventilation group). The AUCs of six scoring systems were calculated for groups A and B, and the ROC curves were compared independently.ResultsA total of 2988 patients were recruited, male accounted for 49.4%, median age was 67 (55, 79), and ICU mortality was 13.2%. The AUCs of SAPSⅡ, LODS, APSⅢ, OASIS, SOFA and SIRS were 0.73 (0.70, 0.75), 0.71 (0.68, 0.73), 0.69 (0.67, 0.72), 0.69 (0.67, 0.72), 0.67 (0.64, 0.70) and 0.58 (0.56, 0.62). Subgroup analysis showed that in group A, the AUCs of OASIS, SAPSⅡ, LODS, APSⅢ, SOFA and SIRS were 0.81 (0.76, 0.85), 0.80 (0.75, 0.85), 0.77 (0.72, 0.83), 0.75 (0.70, 0.80), 0.73 (0.68, 0.78) and 0.63 (0.56, 0.69) in the prediction of ICU mortality; in group B, the AUCs of SAPSⅡ, APSⅢ, LODS, SOFA, OASIS and SIRS were 0.68 (0.64, 0.71), 0.67 (0.63, 0.70), 0.65 (0.62, 0.69), 0.62 (0.59, 0.66), 0.62 (0.58, 0.65) and 0.57 (0.54, 0.61) in the prediction of ICU mortality. The results of independent ROC curve showed that the AUC differences between groups A and B were statistically significant in terms of OASIS, SAPSⅡ, LODS, APSⅢ and SOFA, but there were no significant differences in SIRS.ConclusionsThe predictive values of six critical illness scores for ICU mortality in respiratory intensive care are low. Lack of ability to predict ICU mortality of patients with invasive mechanical ventilation should hold primary responsibility.

      Release date:2021-04-25 10:17 Export PDF Favorites Scan
    • Introduction to the application of NHANES data weights: implementation in R programming language

      The National Health and Nutrition Examination Survey (NHANES) in the United States is a research program designed to assess the health and nutritional status of adults and children in the country. Due to its adoption of a complex sampling design, it is imperative to correctly apply the weights provided by NHANES to ensure the accuracy and external validity of research results. This article first introduces the relevant concepts of the NHANES database and its weights, followed by a practical demonstration of weight selection, calculation, and implementation in the R programming language. It further discusses the significance of using weights in NHANES data and systematically showcases how to perform weighted analysis based on R, providing a valuable reference for relevant researchers.

      Release date:2025-06-16 05:31 Export PDF Favorites Scan
    • 右心室粘液瘤一例

      Release date:2016-08-30 05:47 Export PDF Favorites Scan
    • Curcumin can inhibit the lipopolysaccharide-induced up-regulation of endogenousβ-glucoronidase expression

      ObjectiveTo investigate the effect of curcumin on the expression regulation of endogenousβ-glucoronidase (β-GD) induced by lipopolysaccharide (LPS).Methods① Human normal intrahepatic biliary epithelial cell line (HiBEpiC) cells in the logarithmic growth phase were divided into blank control group (0 h group) and 7 different stimulation time groups. The cell density was adjusted to 1×104/mL, and the cells were stimulated with 100 mg/mL LPS for 1, 3, 6, 18, and 24 hours respectively, including another two groups where the cells were cultured with LPS-free medium for 18 and 24 hours after LPS stimulation for 24 h. ② HiBEpiC cells in the logarithmic growth phase were divided into blank control group, LPS+low, medium, and high concentration curcumin group. The cell density was adjusted to 1×104/mL. In the blank control group, cells were not stimulated with any reagent; in the LPS group, cells were stimulated with 100 mg/mL LPS, in the other three groups, the cells were stimulated with 100 mg/mL LPS and simultaneously 20, 40, and 80 μmol/L curcumin, respectively, for 24 hours. The expressions of c-myc and endogenous β-GD were detected by Western blot method.Results① The expressions of endogenous β-GD and c-myc in HiBEpiC cells gradually increased with the prolongation of treatment time by LPS, and the expression levels of β-GD and c-myc at each time point group were significantly different from those in the 0 h group (P<0.05). ② There were significant difference between any two groups of the blank control group, LPS group, LPS+low concentration of curcumin group, LPS+medium concentration of curcumin group, and LPS+high concentration of curcumin group (P<0.05).ConclusionCurcumin is able to inhibit the increased expression of endogenous β-GD induced by LPS, possibly via inhibiting expression of c-myc.

      Release date:2019-08-12 04:33 Export PDF Favorites Scan
    • 甲狀腺惡性腫瘤臨床評估量表的初步編制

      目的編制甲狀腺惡性腫瘤臨床評估量表(CAS-T),檢驗CAS-T的效度和信度,評估甲狀腺惡性腫瘤患者的臨床狀況。 方法在小組討論和專科咨詢后,初步設計調查方向及條目,通過預調查-分析篩選條目-再調查-條目分析與修訂-正式調查等環節,確定量表最終條目。選取308例患者施測,評定CAS-T的結構效度及信度;用癌癥治療功能性量表-頭頸版(FACT-H & N總)施測,評定CAS-T的效標效度;于出院當天重測,評定CAS-T重測信度。 結果CAS-T共42個項目,包含情感狀況、家庭狀況、社交狀況、身體功能狀況、甲狀腺專科模塊5個維度,共解釋總方差的79.603%;本量表與FACT-H & N總得分及各因子得分均呈正相關(r=0.48~0.63,均P<0.01);總量表的Cronbachα系數為0.87,5個維度的Cronbachα系數為0.51~0.75;總量表的重測信度為0.89,5個維度的重測信度為0.53~0.81。 結論本研究編制的量表具有良好的效度和信度,可用于甲狀腺惡性腫瘤患者的臨床狀況。

      Release date: Export PDF Favorites Scan
    • Prophylactic Level VI Dissection for Stage cN0 Papillary Thyroid Carcinoma: A Meta-analysis

      ObjectiveTo systematically evaluate the effectiveness and safety of prophylactic central neck dissection (PCND) for stage cN0 papillary thyroid carcinoma. MethodsDatabases including PubMed, EMbase, The Cochrane Library (Issue 1, 2015), WanFang Data, CBM and CNKI were searched to collect the studies about total thyroidectomy (TT)+PCND versus TT alone for stage cN0 papillary thyroid carcinoma from inception to March 2015. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was performed by using RevMan 5.1 software. ResultsA total of 10 studies involving 3 661 patients were included. The results of meta-analysis showed that, compared with TT alone, TT+PCND had higher transient hypocalcemia (OR=2.50, 95%CI 2.05 to 3.03, P<0.000 01), higher permanent hypocalcemia (OR=3.11, 95%CI 1.82 to 5.30, P<0.000 1), and lower recurrence (OR=0.66, 95%CI 0.47 to 0.93, P=0.02). But there were no significant differences between two groups in transient laryngeal nerve palsy or permanent laryngeal nerve palsy. ConclusionTT+PCND is safe and feasible for treating stage cN0 papillary thyroid carcinoma when its indications are strictly controlled. However, due to limited quantity and quality of the included studies, more high-quality randomized controlled trials are needed to verify the abovementioned conclusion.

      Release date: Export PDF Favorites Scan
    3 pages Previous 1 2 3 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南